| OA13.03 | Acceptability of telemedicine and HIV self-test among PrEP users during the COVID-19 pandemic in Brazil | Oral Abstract Session | Implementation science, including structural interventions, PrEP & VMMC |
| OA13.02 | Social, economic, mental health and medical care impacts of COVID-19 in a US cohort of sex and gender diverse adolescents and young adults at-risk for HIV | Oral Abstract Session | Behavioural and social science research |
| OA13.01 | Implementing a rapid response to the COVID-19 global pandemic in MTN-034/REACH: an HIV prevention trial among adolescent girls and young women in Africa | Oral Abstract Session | Ethics in HIV prevention research |
| OA12.05 | Improved in vitro expression and in vivo immunogenicity of a candidate MVA-vectored HIV-1 vaccine compared to SAAVI MVA-C | Oral Abstract Session | Novel vaccine and other prevention approaches |
| OA12.04LB | A VSV-based HIV-1 vaccine provides protection in macaques against low dose cross-clade SHIVenv_SF162_P3 challenge | Oral Abstract Session | Novel vaccine and other prevention approaches |
| OA12.03 | Tetravalent immunogen assembled from conserved regions of HIV-1 and delivered as mRNA demonstrates potent preclinical T cell immunogenicity and breadth | Oral Abstract Session | Novel vaccine and other prevention approaches |
| OA12.02 | Comparison of co-immunization of DNA and protein in the same anatomical sites and in contralateral sites to identify mechanisms of protective immune response | Oral Abstract Session | Novel vaccine and other prevention approaches |
| OA12.01 | Fine-tuning of in vitro transcribed mRNA for optimising a vaccine platform against HIV-1 | Oral Abstract Session | Novel vaccine and other prevention approaches |
| OA11.05LB | Transient changes in daily sexual behavior and pre-exposure prophylaxis use after the implementation of COVID-19 restrictions among men who have sex with men | Oral Abstract Session | Implementation science, including structural interventions, PrEP & VMMC |
| OA11.04 | Integrating STI screening into PrEP services for adolescent girls and young women (AGYW) in two primary health care (PHC) facilities in Johannesburg: lessons from Prevention Options for Women Evaluation Research (POWER) | Oral Abstract Session | Delivery technologies: novel approaches, formulation and multi-purpose |